What is the appropriate oral and intrathecal dosing of baclofen for adult spasticity, how should the dose be adjusted in renal impairment, and what are its common adverse effects and precautions?

Baclofen Dosing and Management for Adult Spasticity

Oral Baclofen Dosing

Start oral baclofen at 5-10 mg/day and titrate slowly every 2-5 weeks to a target dose of 30-80 mg/day divided into 3-4 doses, with mandatory dose reduction in renal impairment. 1

Standard Dosing Protocol

• Initial dose: 5-10 mg/day 1, 2
• Titration: Increase gradually every 2-5 weeks 1
• Target dose: 30-80 mg/day divided into 3-4 doses 1, 2
• Trial duration: Allow 4-8 weeks at maximum tolerated dose before declaring treatment failure 1

Renal Impairment Adjustments

• Patients with moderate or greater renal impairment must start with the lowest dose (5 mg/day) due to renal clearance 1
• Baclofen is renally cleared and drug half-life can increase two- to three-fold in elderly patients with elevated serum creatinine 1
• Titrate more slowly (every 2-5 weeks) in patients with impaired renal function 1
• Limited data suggest baclofen administration in renal disease carries unnecessarily high risk 3

Special Populations

• Elderly patients (>70 years): Use lower initial doses and slower titration due to altered pharmacokinetics and increased susceptibility to adverse effects 1
• Medically frail patients: Use slower titration schedule similar to elderly patients 1

---

Intrathecal Baclofen Therapy

Intrathecal baclofen is indicated for severe spasticity unresponsive to maximum doses of oral baclofen, with only 10% of the systemic dose required for equianalgesia. 1, 2

Indications

• Severe spastic hypertonia unresponsive to oral baclofen, tizanidine, or dantrolene 1, 2
• Chronic spasticity causing pain, poor skin hygiene, or decreased function 1
• Can be considered as early as 3-6 months after stroke for refractory cases 2

Efficacy

• >80% of patients show improvement in muscle tone 1
• >65% of patients show improvement in spasms 1, 4
• Effectiveness sustained for years without tolerance development 1

Dosing Considerations

• Only 1/100th of oral dose required intrathecally 1, 5
• Programmable pump allows precise dose titration over 24-hour period 4
• Can vary doses throughout day (lower during day for ambulation, higher at night for sleep) 5

---

Treatment Algorithm for Spasticity

First-Line: Non-Pharmacological Approaches

Begin with antispastic positioning, range of motion exercises, stretching, splinting, and serial casting before initiating pharmacological therapy. 1, 2

Second-Line: Pharmacological Options

• Focal spasticity: Botulinum toxin is preferred over baclofen 1, 2
• Generalized spasticity: Oral baclofen, tizanidine, or dantrolene 1, 2
• Severe refractory spasticity: Intrathecal baclofen 1, 2

Last Resort: Neurosurgical Procedures

• Selective dorsal rhizotomy or dorsal root entry zone lesion 1

---

Common Adverse Effects

Oral Baclofen

• Sedation or somnolence (most common) 3
• Excessive weakness 3
• Dizziness and vertigo 1, 3
• Mental confusion 1, 3
• Gastrointestinal symptoms 1
• Incidence of adverse effects ranges from 10-75%, most are dose-related and transient 3
• Adverse effects typically appear at doses >60 mg/day 5
• Treatment discontinuation due to intolerable effects occurs in 4-27% of patients 5

Intrathecal Baclofen

• Overdose symptoms (primarily from test doses or programming errors) 4
• Mechanical complications involving catheter (most common) 4, 6
• Decreased level of consciousness (reported in some cases) 7

---

Critical Safety Precautions

Withdrawal Syndrome

Abrupt cessation of baclofen, especially intrathecal, can cause life-threatening withdrawal syndrome with high fever, altered mental status, rebound spasticity, muscle rigidity, seizures, hallucinations, delirium, tachycardia, and potentially death. 1

• Withdrawal syndrome evolves over 1-3 days and may become fulminant if not recognized 1
• Best management: Resume intrathecal infusion immediately 1
• High-dose oral baclofen may not prevent acute withdrawal in patients on intrathecal therapy 1
• Never abruptly discontinue in long-term users; taper slowly over weeks 1
• Continue baclofen preoperatively, including day of surgery, to avoid withdrawal 1
• Maintain regular pump refill schedule to prevent withdrawal 1

Drug Interactions and Contraindications

• Avoid benzodiazepines (e.g., diazepam) during stroke recovery due to deleterious effects on recovery 1, 2
• Use extreme caution with other CNS depressants due to additive sedation 1
• Avoid in significant hepatic dysfunction due to increased CNS effects 1
• Can cause respiratory depression, particularly in overdose; use with extreme caution in compromised respiratory function 1
• May worsen obstructive sleep apnea by promoting upper airway collapse 1

Monitoring Requirements

• Monitor supine and standing blood pressure 1
• Monitor renal function and serum creatinine 1
• Assess fall risk, especially in post-stroke patients 1
• Regular follow-up for pump refills in intrathecal therapy patients 1

---

Clinical Pitfalls and Caveats

When Baclofen is NOT Appropriate

• Focal spasticity: Botulinum toxin is more effective than baclofen 1, 2
• Neuropathic pain: Gabapentinoids (pregabalin, gabapentin) are first-line, not baclofen 1
• Flaccid hemiplegia with "spasms": These are usually painful muscle contractions related to neuropathic pain, not true spasticity; treat with gabapentinoids instead 1
• Low back pain: Only sparse data (2 trials) support baclofen's efficacy 1

Common Misuse

• Baclofen provides little benefit at low doses and may worsen motor function in flaccid conditions 1
• In post-stroke hand contractures, botulinum toxin is strongly recommended as first-line over baclofen 1
• Baclofen is primarily for spasticity, not pain management 1

Tizanidine as Alternative

• Tizanidine has equivalent efficacy to baclofen but better tolerability, particularly less weakness 1
• Consider tizanidine as preferred alternative, especially in patients at risk for weakness 1